Coronado Biosciences Secures $14,118,534 New Financing Round

  • Feed Type
  • Date
    1/20/2011
  • Company Name
    Coronado Biosciences
  • Mailing Address
    45 Rockefeller Plaza New York, NY 10111
  • Company Description
    Coronado Biosciences is a clinical stage biopharmaceutical company focused on making cancer care better. How do we define better? We hope to make cancer care safer and more easily tolerated with improved outcomes.
  • Website
    http://www.CoronadoBioSciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $14,118,534
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Represents value of certain shares of the issuer’s preferred stock which were exchanged as consideration for the acquisition of certain assets. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.